Trial · NCT07888894
Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders
NCT07888894, Not applicable, Not yet recruiting, Uppsala University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders. Trials, record NCT07888894. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888894
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders
- NCT number
- NCT07888894
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Uppsala University
- Conditions
- Psychoses, Metabolic Syndrome
- Interventions
- Targeted Health Dialogues
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes from baseline in Body Mass Index after 12 months | From enrollment to the end of the sudy at 12 months | |
| Secondary | Canges from baseline in Lipid profile at 12 months | From enrollment to the end of the study after 12 months | Lipid profile is blood test values collected from patient records. Lipid profile include total-cholesterol, triglycerides, HDL-Cholesterol and LDL-cholesterol. |
| Secondary | Changes from baseline in HbA1C mmol/mol at 12 months | From enrollment to the end of the study at 12 months | |
| Secondary | Changes from baseline in waist-to hip ratio after 12 months | From enrollment to the end of the study at 12 months | |
| Secondary | Canges from baseline in blood preassure at 12 months | From enrollment to the end of treatment at 12 months | |
| Secondary | Changes from baseline in EuroQol Visual Analogue Scale at 12 months | From enrollment to the end of the study at 12 months | Range from 0 to 100. 0 represents worse possible healthstatus and 100 represents best possible health status |
| Secondary | Changes from baseline in fasting plasma glucose at 12 months | From enrollment to end of the study at 12 months | Bloodtest measuring fasting plasma glucose in mmol/L |
| Secondary | Changes from baseline in RAND 36-Item Health Survey at 12 months | From enrollment to end of the study at 12 months | 8 health dimension are measured Range from from 0-100. Where a higher score means better function/health |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888894
GET https://conductscience.org/api/trials/v1/NCT07888894/registered